News and Trends 14 Nov 2018 Parkinson’s Disease Vaccine Shows Preclinical Promise The biotech company United Neuroscience has developed a candidate Parkinson’s disease vaccine that targets a protein linked to the condition. The vaccine teaches the immune system to attack aggregations of… November 14, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Interview 13 Mar 2017 Meet the Omics Entrepreneur who also Co-Founded EMBL …you comment on how you find it in Germany? Compared to the United States, Germany has a much shorter tradition in biotech. It was first at the end of the… March 13, 2017 - 7 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
Best in Biotech 21 Nov 2025 Six key obesity deals in 2025 …global net sales. Novo Nordisk and The United Laboratories In March, Novo decided to take a bet on a “triple G” obesity drug as it forged a $2 billion deal with The… November 21, 2025 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
More News! 8 Feb 2017 The FDA lays down Laws of Interchangeability: New Era for Biosimilars? …and future drugs as more products can be substituted for a reference by a pharmacist without the approval of a health care provider. The United States did have an “interchangeable”… February 8, 2017 - 4 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 27 Jun 2022 Saudi Arabia to inject $3B into vaccines and medicines industry …vital medicines committee, Bandar bin Ibrahim Alkhorayef, has announced the launch of several investment opportunities in the vaccines and vital medicines industry, valued at $3.4 billion, to achieve the Kingdom’s… June 27, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Country A – Z Index …Latin America M Malaysia N Netherlands New Zealand Norway P Poland Portugal R Russia S Saudi Arabia Scotland Singapore South Korea Spain Sweden Switzerland T Taiwan U United Kingdom USA… March 24, 2023 - 0 minutesmins - By Developer Share WhatsApp Twitter Linkedin Email
News and Trends 3 Apr 2017 New Results Show GM Mosquitoes Keep Dengue and Zika at Bay in Brazil In its second year, Oxitec has reduced the mosquito population in a Brazilian neighborhood by 81%, demonstrating the long-term potential of GM insects. Oxitec is a spin-out from the University… April 3, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 8 Sep 2022 OncoBone signs deals with three partners to work on bone metastases OncoBone Ventures has signed cooperation framework agreements with three partners. The company is a U.K. start up biotech looking to develop novel therapies for cancer patients with currently incurable bone… September 8, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 8 May 2017 Immunocore Boosts its Collaboration with GSK with new Lead Compound Immunocore has singled out a new lead candidate in its immuno-oncology discovery program with GSK, triggering an undisclosed milestone payment to Immunocore. Based in Oxford, Immunocore is one of the… May 8, 2017 - 2 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
News and Trends 1 Sep 2017 Allergan Takes to the Clinic a New Alzheimer’s Drug from a €3Bn Deal Allergan’s partner Heptares Therapeutics has dosed the first patient with a GPCR drug to treat major symptoms of Alzheimer’s disease. A year ago, Allergan signed a massive deal of up… September 1, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 11 Oct 2018 Rechargeable Dentures Could Prevent Mouth Infections As well as helping you chew your hamburger, dentures could one day fight oral fungal infections, suggest researchers from Manchester Metropolitan University, UK. The population is getting older. In fact,… October 11, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 13 Oct 2016 Adaptimmune Revises TCR Protocol following Phase I/IIa Failure Shares of Adaptimmune slid 12% yesterday morning after the company updated its TCR therapy to include fludarabine, which was linked to deaths in Juno’s CAR-T trials. Despite optimism that T-cells… October 13, 2016 - 2 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email